FAR Biotech is a preclinical, computational drug discovery company that focuses on hard-to-drug targets with high scientific and commercial value.
Founded by Dr Martin Martinov after 25 years in academia and industry -- and named after the Bulgarian word “far” that translates into “lighthouse” or “beacon” -- FAR seeks to shine a light on drug discovery in areas of high unmet clinical need.
FAR's proprietary technology can more rapidly identify novel, structurally diverse, optimized, lead molecules that other approaches would not look for, let alone find. The key differentiator is FAR's complete and rigorous quantum mechanical representation of drug-target interactions -- which embeds the advantages of quantum similarity and multi-property optimization for hit and lead identification -- augmented by AI / machine learning & big data.
FAR's quantum biomodelling platform has been validated preclinically across a number of therapeutic areas, including neurodegeneration, oncology and infectious diseases.
Company Details
- Employees
- 5
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- farbiotech.com
Far Biotech Questions
Far Biotech's website is farbiotech.com
Far Biotech's LinkedIn profile is https://www.linkedin.com/company/far-biotech
Far Biotech has
5 employees.
View email and phone details for 5
employees at Far Biotech.
Far Biotech's industry is
Biotechnology Research
Far Biotech's top competitors are
Abingdon Health Plc,
Heliowave Technologies Corp,
Texel.ai,
Promptbio,
Rpd Energy,
Masa Impact,
Radiolife,
Movespot,
Coop,
Ctcells.
Far Biotech's categories are Biotechnology Research
